Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:23 Feb 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1182.75 [ -2.05% ]TCS 2481.80 [ +2.92% ]

Sensex28892.97
28.26 0.10%

Nifty8939.50
12.60 0.14%

Midcap13532.11
25.18 0.19%

Smallcap13587.78
14.75 0.11%


Bse Corporate Announcements Back
Sun Pharma announces USFDA approval for generic Diltiazem ER
Sun Pharma announces USFDA approval for generic Diltiazem ER Sun Pharmaceutical Industries has announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac extended release capsules. These generic Tiazac capsules contain Diltiazem Hydrochloride Extended- release USP, 120 mg, 180 mg, 240 mg, 300 mg and 360 mg, and are therapeutically equivalent to Biovail Corporations Tiazac extended release capsules. Generic Tiazac Capsules are indicated for the treatment of hypertension, used alone or in combination with other antihypertensive medications. Generic Tiazac Capsules are also used in the treatment of Chronic stable angina. The company made this announcement during the trading hours today, 18 November 2010.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com